Catalyst Wire Dossier Catalyst Wire Dossier

Depo-SubQ Provera 104

medroxyprogesterone acetate · Pfizer
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Depo-SubQ Provera 104, covering 2011-08-11 to 2014-09-18. Get the full timeline:

Most recent: Clinical Trial Update: Acceptability of Depo-subQ Provera 104 in Uniject vs. Intramuscular Depo-Provera Among HIV+ Women & Providers, Uganda [NA]

See pricing